I am an assistant professor at the department Biomedical Engineering (research group Computational Biology), working on systems biology for oncology. In my group we investigate why patients differentially respond to cancer therapy, and how personalized therapy based on biomarkers can be developed. In particular, we approach the complex problem of precision medicine by applying dynamic mathematical modeling approaches and machine learning techniques to investigate signaling pathways, their deregulation in cancer, and the specific effect of targeted therapy. Since precision medicine would largely benefit from the possibility to perform phenotypic drug screening directly on live patient tumor cells, I have also been collaborating on the development of a microfluidics platform for this purpose. More recently we are expanding our research to study the interaction between tumor and immune cells, using a systems biology approach to tackle the multiple open questions of immuno-oncology.